BioRestorative Therapies, Inc.
Close on Oct 19, 2026
- Market cap
- $28.36M
- P/E (TTM)
- –
- Dividend yield
- –
Earnings
Quarterly results announced on Form 8-K, Item 2.02
| Quarter | Reported | Time | Revenue | EPS (GAAP) | EPS (adjusted) |
|---|---|---|---|---|---|
| Q3 FY2025 Ended Sep 30, 2025 | Nov 12, 2025 | After market close | – | – | – |
| Q2 FY2025 Ended Jun 30, 2025 | Aug 12, 2025 | After market close | – | – | – |
| Q1 FY2025 Ended Mar 31, 2025 | May 14, 2025 | After market close | – | – | – |
| Q4 FY2024 Ended Dec 31, 2024 | Mar 27, 2025 | After market close | – | – | – |
| Q3 FY2024 Ended Sep 30, 2024 | Nov 13, 2024 | After market close | $230.70K | $-0.13 | – |
| Q2 FY2024 Ended Jun 30, 2024 | Aug 13, 2024 | After market close | – | – | – |
Press releases
Announcements BioRestorative Therapies filed with the SEC
PRESS RELEASE, DATED SEPTEMBER 2, 2026
Charter or bylaw amendment · Regulation FD disclosure · EX-99.1 to Form 8-K
EX-99.1 to Form 8-K
Regulation FD disclosure · EX-99.1 to Form 8-K
Announces Pricing of $5.0 Million Public Offering
Material agreement · Regulation FD disclosure · EX-99.1 to Form 8-K
Announces Closing of $5.0 Million Public Offering
Material agreement · Regulation FD disclosure · EX-99.2 to Form 8-K
EX-99.1 to Form 8-K
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
Therapies Announces $1.085 Million Registered Direct Offering Priced Above Market
Material agreement · Unregistered share sale · Regulation FD disclosure · EX-99.1 to Form 8-K
EX-99.1 to Form 8-K
Regulation FD disclosure · EX-99.1 to Form 8-K
PRESS RELEASE DATED AUGUST 12, 2025
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
PRESS RELEASE DATED JUNE 13, 2025
Regulation FD disclosure · EX-99.1 to Form 8-K
EX-99.2 to Form 8-K
Regulation FD disclosure · EX-99.2 to Form 8-K
EX-99.1 to Form 8-K
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
EX-99.1 to Form 8-K
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
EX-99.1 to Form 8-K
Regulation FD disclosure · EX-99.1 to Form 8-K
EX-99.2 to Form 8-K
Regulation FD disclosure · EX-99.2 to Form 8-K
PRESS RELEASE DATED NOVEMBER 12, 2024
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
PRESS RELEASE DATED NOVEMBER 13, 2024
Results of operations · Regulation FD disclosure · EX-99.2 to Form 8-K
EX-99.3 to Form 8-K
Results of operations · Regulation FD disclosure · EX-99.3 to Form 8-K
EX-99.1 to Form 8-K
Regulation FD disclosure · EX-99.1 to Form 8-K
PRESS RELEASE RE SECOND QUARTER RESULTS
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
EX-99.1 to Form 8-K
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
PRESS RELEASE DATED MARCH 11, 2024
Regulation FD disclosure · EX-99.1 to Form 8-K
EX-99.2 to Form 8-K
Regulation FD disclosure · EX-99.2 to Form 8-K
BioRestorative Therapies Announces Exercise of Warrants and Issuance of New Warrants in a Private Placement for $8.1 Million
Material agreement · Unregistered share sale · Other events · EX-99.1 to Form 8-K
BioRestorative Therapies Presents Preliminary Clinical Data from Phase 2 Study of BRTX-100 in Chronic Lumbar Disc
Regulation FD disclosure · EX-99.1 to Form 8-K
EX-99.2 to Form 8-K
Regulation FD disclosure · EX-99.2 to Form 8-K
EX-99.1 to Form 8-K
Regulation FD disclosure · EX-99.1 to Form 8-K
PRESS RELEASE DATED JULY 11, 2023
Material agreement · Other events · EX-99.1 to Form 8-K
EX-99.1 to Form 8-K
Material agreement · Auditor change · Charter or bylaw amendment · Regulation FD disclosure · EX-99.1 to Form 8-K
PRESS RELEASE RE PUBLIC OFFERING
Unregistered share sale · Regulation FD disclosure · EX-99.1 to Form 8-K
L. ALSTODT NON-QUALIFIED STOCK OPTION AWARD AGREEMENT
Material agreement · Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
F. SILVA NON-QUALIFIED STOCK OPTION AWARD AGREEMENT
Material agreement · Executive or director change · Regulation FD disclosure · EX-99.2 to Form 8-K
PRESS RELEASE DATED NOVEMBER 4, 2021
Material agreement · Executive or director change · Regulation FD disclosure · EX-99.3 to Form 8-K
PRESS RELEASE DATED OCTOBER 26, 2021
Charter or bylaw amendment · Other events · EX-99.1 to Form 8-K